Plasma adiponectin levels and incident glucose intolerance in Japanese-Brazilians: A seven-year follow-up study

Diabetes Research and Clinical Practice

Volumn 73, Issue 3, 2006, Pages 304-309

  Vendramini, Marcio F ^a   Ferreira, Sandra R G ^a   Gimeno, Suely G A ^a   Kasamatsu, Teresa S ^a   Miranda, Walkiria L ^a   Moisés, Regina S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adiponectin; Japanese Brazilians

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; LIPID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE; RISK FACTOR; SEX RATIO; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; BRAZIL; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; JAPAN; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33746322475     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.02.002     Document Type: Article

References (27)

1. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodishi H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270 (1995) 26746-26749
2. Hotta K., Funahashi T., Bodkin N.L., Ortmeyer H.K., Arita Y., Hansen B.C., et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50 (2001) 1126-1133
3. Fasshauer M., Klein J., Neumann S., Eszlinger M., and Paschke R. Adiponectin gene expression is inhibited by beta adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 507 (2001) 142-146
4. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Weight reduction increases plasma levels of an adipose-derived antiinflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 86 (2001) 3815-3819
5. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., et al. PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose derived protein. Diabetes 50 (2001) 2094-2099
6. Hirose H., Kawai T., Yamamoto Y., Taniyama M., Tomita M., Matsubara K., et al. Effects of pioglitazone on metabolic parameters, body fat distribution and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism 51 (2002) 314-317
7. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., and Prins J.B. Adiponectin-a key adipokine in the metabolic syndrome. Diabet. Obes. Metab. (2005) 1-17
8. Lindsay R.S., Funahashi T., Hanson R.L., Matsuzawa Y., Tanaka S., Tataranni P.A., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360 (2002) 57-58
9. Daimon M., Oizumi T., Saitoh T., Kameda W., Hirata A., Yamaguchi H., et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: The Funagata Study. Diabet. Care 26 (2003) 2015-2020
10. Spranger J., Kroke A., Mohlig M., Bergmann M.M., Ristow M., Boeing H., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361 (2003) 226-228
11. Snehalatha C., Mukesh B., Simon M., Viswanathan V., Haffner S.M., and Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabet. Care 26 (2003) 3226-3229
12. Duncan B.B., Schmidt M.I., Pankow J.S., Bang H., Couper D., and Ballantyne C.M. Adiponectin and development of type 2 diabetes: The Atherosclerosis Risk in Communities Study. Diabetes 53 (2004) 2473-2478
13. Gimeno S.G.A., Ferreira S.R.G., Franco L.J., Hirai A.T., Matsumura L., and Moisés R.S. Prevalence and 7-year incidence of type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia 45 (2002) 1635-1638
14. Gimeno S.G.A., Osiro K., Matsumura L., Massimino F.C., Ferreira S.R.G., and Japanese-Brazilians Diabetes Study Group. Glucose intolerance and all-cause motality in Japanese migrants. Diabet. Res. Clin. Pract. 68 (2005) 147-154
15. Vieira J.G., Nishida S.K., Lombardi M.T., Tachibana T.T., Obara L.H., Dalbosco I.S., et al. Comparison of the determination of insulin by a monoclonal antibody-based immunofluorimetric assay and by radioimmunoassay. Braz. J. Med. Biol. Res. 28 (1995) 537-554
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
17. K.G.M.M. Alberti, P.Z. Zimmet, for the World Health Organization Consultation, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus, Report of a WHO Consultation, 1999, WHO, Geneva.
18. Retnakaran R., Hanley A.J., Raif N., Connelly P.W., Sermer M., and Zinman B. Hypoadiponectinaemia in South Asian women during pregnancy: evidence of ethnic variation in adiponectin concentration. Diabet. Med. 21 (2004) 388-392
19. Hulver M.W., Saleh O., MacDonald K.G., Pories W.J., and Barakat H.A. Ethnic differences in adiponectin levels. Metabolism 53 (2004) 1-3
20. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index in the Japanese population. Clin. Sci. 103 (2002) 137-142
21. Matsubara M., Maruoka S., and Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J. Clin. Endocrinol. Metab. 87 (2002) 2764-2769
22. Tschritter O., Fritsche A., Thamer C., Haap M., Shirkavand F., Rahe S., et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52 (2003) 239-243
23. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb. Vasc. Biol. 20 (2000) 1595-1599
24. Combs T.P., Berg A.H., Rajala M.W., Klebanov S., Iyengar P., Jimenez-Chillaron J.C., et al. Sexual differentiation, pregnancy, caloric restriction and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52 (2003) 268-276
25. Weyer C., Funahashi T., Tanaka S., Tanaka S., Hotta K., Matsuzawa Y., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86 (2001) 1930-1935
26. Stefan N., Vozarova B., Funahashi T., Matsuzawa Y., Weyer C., Lindsay R.S., et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosin phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51 (2002) 1884-1888
27. Rakatzi I., Mueller H., Ritzeler O., Tennagels N., and Eckel J. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 47 (2004) 249-258